Specifically, several immune checkpoints including TNFRSF18, TNFRSF4, VSIR, LGALS9, HAVCR2, and TNFRSF14 are significantly associated with RARA-AS1 in more than 10 types of cancer. This evidence concerns the gene RARA and cancer.